Parallel Advisors »

Mineralys Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $284 22 12.91
2023-12-31 $1.4k 159 8.60

More positions owned by Parallel Advisors

Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Ishares S&p 500 Index Etf (IVV)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Corcept Therapeutics Stock (CORT)
Ishares Msci Usa Quality Factor Etf Etf (QUAL)
Microsoft Stock (MSFT)
Amazon.com Stock (AMZN)
Guggenheim Etf Trust S&p 500 Equal Weight Etf (RSP)
Ishares Aggregate Bond Etf Etf (AGG)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Large Cap Etf (VV)
Cvb Finl Corp Stock (CVBF)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)

View all positions for Parallel Advisors

Top funds holding Mineralys Therapeutics

Samsara BioCapital
RA Capital Management
Braidwell
Sr One Capital Management
BlackRock
Laurion Capital Management
Vanguard Group
Sphera Funds Management
Franklin Resources
Blue Owl Capital Holdings
Millennium Management
Point72 Asset Management
Charles Schwab Investment Management
Citadel Advisors
Two Sigma Investments

View all funds holding Mineralys Therapeutics